CURRENT
ISSUE
1578
August 12, 2019

Anxiety disorders (generalized anxiety disorder, panic disorder, social anxiety disorder, and various phobias) are the most common form of psychiatric illness. They can be treated effectively with cognitive behavioral therapy (CBT) and/or pharmacotherapy. Obsessive-compulsive disorder and posttraumatic stress disorder are now considered separate entities in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5); they can also be treated with CBT and many of the same drugs.1

PHARMACOTHERAPY

Many different classes of drugs are used for treatment of...  Continue reading

More from Issue 1578
Previous Issue: 1577      July 29, 2019
Coming Soon
Solriamfetol (Sunosi) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
Insect Repellents
Drugs for Atrial Fibrillation
Search
Subscribe
Conversation
Follow us  facebook        Email Alerts
 Tweets
Advance Release
ADVANCE
RELEASE
The FDA has approved Qmiiz ODT (TerSera), an orally disintegrating tablet formulation of the prescription NSAID meloxicam. Qmiiz ODT, like conventional oral meloxicam tablets (Mobic, and generics), is indicated for relief of the symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA) in adults and of juvenile RA in children who weigh ≥60 kg. Vivlodex, a low-dose capsule formulation of meloxicam, is FDA-approved only for management of OA pain. ... Continue reading